Albemarle cautious on lithium outlook, consensus keeps the shares in focus
Published on 06/30/2026 at 10:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 10:12.
Albemarle Corp. (US0126531013) sits in the global lithium supply chain as one of the larger listed producers on the NYSE under the ticker ALB. The stock is part of the S&P 500 chemicals cohort, where investors regularly track earnings estimates and valuation metrics across peers.
Analyst focus on earnings and valuation
Analyst coverage on Albemarle typically centers on expected earnings per share, free cash flow generation and the trajectory of lithium pricing in key markets such as China and South America. Consensus models often group the company alongside sector peers like SQM and Livent when comparing margins and capital expenditure levels.
Research houses regularly publish updates on Albemarle with rating distributions that range across Buy, Hold and Sell recommendations, using price targets that reflect assumptions about long-term lithium demand from electric vehicle and energy storage sectors. These notes frequently benchmark Albemarle against broader S&P 500 chemicals valuations on forward earnings multiples.
What consensus numbers tend to show
Publicly available consensus compilations commonly list one-year forward earnings estimates for Albemarle and aggregate target prices into an average that investors use as a reference point rather than a guarantee. The number of contributing analysts is typically in the double digits for a large-cap S&P 500 constituent.
Rating distributions on these consensus pages often show how many houses rate Albemarle at Buy versus Neutral or Sell, providing a quick snapshot of sentiment relative to peers in specialty chemicals and battery materials. Changes in these distributions tend to follow company updates on capital plans, cost structures or market conditions.
Background and price data on Albemarle Corp.
Further company news, regulatory disclosures and price information on Albemarle Corp. are available in the dedicated topic section and on the Investor Relations page.
How Albemarle makes its money
Albemarle generates revenue primarily from the production and sale of lithium compounds used in rechargeable batteries, bromine specialties applied in flame retardants and oilfield chemicals, and catalysts that support petroleum refining processes. These business lines collectively position the company as a diversified specialty chemicals supplier to industrial and energy customers.
Where the Albemarle shares trade today
Albemarle Corp. shares (US0126531013) trade on the NYSE under the ticker ALB in US dollars; the specific price level and market capitalization on 2026-06-30, 10:12 cannot be stated precisely here without current live data, but the listing remains part of the S&P 500 chemicals segment.
Key data on the Albemarle shares
- Company: Albemarle Corporation
- ISIN: US0126531013
- WKN: 890167
- Ticker: ALB
- Trading venue: NYSE
- Price (as of 2026-06-30, 10:12): not live-verifiable in this context
- Market cap: not live-verifiable in this context
- Sector / industry: Specialty chemicals / battery materials
- Index membership: S&P 500
- Next earnings date: not officially scheduled here
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a securities recommendation or an invitation to buy or sell Albemarle Corp. shares or any other financial instrument.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
